MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
LRMR Larimar Therapeutics
- 4.010
- +0.030+0.75%
Close Dec 20 16:00 ET
- 4.090
- +0.080+2.00%
Post 20:01 ET
255.86MMarket Cap-3.49P/E (TTM)
4.170High3.870Low1.14MVolume3.950Open3.980Pre Close4.59MTurnover3.61%Turnover RatioLossP/E (Static)63.81MShares13.68052wk High1.29P/B126.79MFloat Cap3.01052wk Low--Dividend TTM31.62MShs Float664.320Historical High--Div YieldTTM7.54%Amplitude1.530Historical Low4.026Avg Price1Lot Size
About Larimar Therapeutics Company
Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.
Company Profile
SymbolLRMR
Company NameLarimar Therapeutics
Listing DateJun 19, 2014
Issue Price16.00
Founded2005
CEODr. Carole Ben-Maimon, M.D.
MarketNASDAQ
Employees42
Fiscal Year Ends12-31
Address3 Bala Plaza East,Suite 506
CityBala Cynwyd
ProvincePennsylvania
CountryUnited States of America
Zip Code19004
Phone1-844-511-9056
Websitehttp://larimartx.com
Company Executives
- Name
- Position
- Salary
- Dr. Carole Ben-Maimon, M.D.
- Director, President and Chief Executive Officer
- 3.14M
- Dr. Gopi Shankar, F.A.A.P.,M.B.A.,PhD
- Chief Development Officer
- 1.38M
- Dr. Russell G. Clayton, D.O.
- Chief Medical Officer
- --
- Michael Celano
- Chief Financial Officer and Principal Accounting Officer
- 1.42M
- Joseph Truitt
- Chairman of the Board
- 114.96K
- Frank E. Thomas
- Independent Director
- 86.21K
- Dr. Jeffrey W. Sherman, F.A.C.P.,M.D.
- Independent Director
- 56.43K
- Thomas Edward Hamilton
- Independent Director
- 77.77K
- Jonathan S. Leff
- Independent Director
- 79.96K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.